Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

Search Cook Medical

March 22nd, 2016

Midterm follow-up data on a Zenapro clinical study

Six-month interim results from the first clinical study on the Zenapro® Hybrid Hernia Repair Device were released at SAGES 2016 in Boston.1

This is the first clinical study on the use of a hybrid hernia-repair device in humans. This study follows 63 patients who have had a ventral hernia-repair procedure using Zenapro devices.

The patients have an average BMI of 34.5 ± 7.8. A majority of these patients also have comorbidities such as a smoking history, hypertension, and previous abdominal surgeries. The clinical study will conclude after 12 months of following-up with patients.


According to the study’s authors, these interim results show an acceptable recurrence and complication rate.

Watch videos of ventral hernia-repair procedures at


  1. El-Hayek K, Yoo K, Phillips M, et al. First human experience with a hybrid biologic and synthetic mesh: ZenaproTM Hernia Repair Device for Ventral Hernia Repair. Poster presentation at: 2016 Society of American Gastrointestinal and Endoscopic Surgeons Conference; March 16-19; Boston, Massachusetts.